NeuroSense Therapeutics
NRSN
NRSN
7 hedge funds and large institutions have $733K invested in NeuroSense Therapeutics in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
7
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$168K | |
| 2 | +$134K | |
| 3 | +$114K | |
| 4 |
Millennium Management
New York
|
+$68K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$38.7K |
Top Sellers
| 1 | -$397K | |
| 2 | -$65K | |
| 3 | -$48K | |
| 4 |
FIA
FNY Investment Advisers
New York
|
-$3K |